Literature DB >> 12774141

Prophylactic indomethacin reduces grades III and IV intraventricular hemorrhages when compared to early indomethacin treatment of a patent ductus arteriosus.

Toby Debra Yanowitz1, Robyn Wyman Baker, Beverly Sobchak Brozanski.   

Abstract

OBJECTIVE: To determine the relative risk of severe intraventricular hemorrhage (IVH) between two very early indomethacin treatment strategies. STUDY
DESIGN: Retrospective chart review of infants <29 weeks gestation and <1350 g who received either indomethacin prophylaxis or very early echocardiography with indomethacin treatment only if the ductus arteriosus was patent.
RESULTS: A total of one hundred and two infants received prophylactic indomethacin (pINDO). Echochardiography was performed on 158 infants, of whom 117 received indomethacin. Infants receiving pINDO had lower gestational age, but similar birth weight, gender, race, antenatal steroid exposure, delivery mode, Apgar scores, and need for resuscitation as infants evaluated by echocardiography. Grades III to IV IVH was observed less frequently in infants who received pINDO (OR 0.27, 95% CI 0.10 to 0.77, p=0.014). Frequency of side effects and recurrent patent ductus arteriosus did not differ between treatment groups.
CONCLUSION: pINDO reduces severe IVH when compared to an early echocardiography strategy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774141     DOI: 10.1038/sj.jp.7210893

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  8 in total

1.  Variability in cerebral oxygen delivery is reduced in premature neonates exposed to chorioamnionitis.

Authors:  Toby D Yanowitz; Douglas M Potter; A'delbert Bowen; Robyn W Baker; James M Roberts
Journal:  Pediatr Res       Date:  2006-02       Impact factor: 3.756

2.  A risk prediction model for severe intraventricular hemorrhage in very low birth weight infants and the effect of prophylactic indomethacin.

Authors:  M J Luque; J L Tapia; L Villarroel; G Marshall; G Musante; W Carlo; J Kattan
Journal:  J Perinatol       Date:  2013-10-10       Impact factor: 2.521

3.  Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus.

Authors:  Gozde Kanmaz; Omer Erdeve; Fuat Emre Canpolat; Serife Suna Oğuz; Nurdan Uras; Nahide Altug; Ben Greijdanus; Uğur Dilmen
Journal:  Eur J Clin Pharmacol       Date:  2012-11-06       Impact factor: 2.953

4.  Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants.

Authors:  Hussnain Mirza; Abbot R Laptook; William Oh; Betty R Vohr; Barbara J Stoll; Sarah Kandefer; Barbara S Stonestreet
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-01-05       Impact factor: 5.747

5.  A predictive model for SIVH risk in preterm infants and targeted indomethacin therapy for prevention.

Authors:  Rachana Singh; Samuel V Gorstein; Frank Bednarek; Joseph H Chou; Elisabeth C McGowan; Paul F Visintainer
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 6.  Patent ductus arteriosus in preterm infants: do we have the right answers?

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  Biomed Res Int       Date:  2013-12-23       Impact factor: 3.411

7.  Outcomes in infants < 29 weeks of gestation following single-dose prophylactic indomethacin.

Authors:  Jeff Reese; Nathalie L Maitre; Maria Gillam-Krakauer; James C Slaughter; Robert B Cotton; Blaine E Robinson
Journal:  J Perinatol       Date:  2020-09-18       Impact factor: 2.521

8.  Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan.

Authors:  Satoshi Kusuda; Masanori Fujimura; Atsushi Uchiyama; Satsuki Totsu; Katsura Matsunami
Journal:  Pediatr Res       Date:  2012-08-24       Impact factor: 3.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.